샘플 요청 목록

 카트 문의
시장보고서
상품코드
1485738

HERG 스크리닝 시장 : 유형별, 이온채널별, 검사법별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

HERG Screening Market, By Type, By Ion Channel, By Testing Methods, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 287 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

HERG 스크리닝 시장 규모는 2023년에 11억 2,445만 달러에 달하며, 2024-2032년 CAGR 10.9%로 확대

HERG 스크리닝 시장 - 시장 역학

약제 혁신의 증가와 심혈관질환의 유병률이 시장 성장을 촉진

HERG 스크리닝 시장은 약물 혁신 증가와 심혈관 질환의 유병률 증가로 인해 강력한 성장세를 보이고 있습니다. 예를 들어 세계보건기구(WHO)에 따르면 심혈관 질환은 여전히 세계 주요 사망 원인으로 연간 1,790만 명이 사망하는 것으로 추산되고 있습니다. 또한 미국 식품의약국(FDA)은 부작용을 줄이기 위해 의약품 개발 중 심장 안전성 평가의 중요성을 강조하며 HERG 스크리닝의 중요한 역할을 강조하고 있습니다. 제약회사들이 신약 및 치료법 개발에 집중하면서 심혈관 질환에 대한 보다 안전하고 효과적인 치료법을 확보하기 위해 HERG 스크리닝 서비스에 대한 수요는 지속적으로 증가하고 있습니다.

HERG 스크리닝 시장 - 주요 인사이트

당사의 리서치 분석가들의 분석에 따르면 세계 시장은 예측 기간(2024-2032) 동안 연평균 약 10.9%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

유형 세분화에 따라 KCNH2 유전자는 2023년 가장 큰 시장 점유율을 보일 것으로 예측되었습니다.

이온 채널 세분화에 따르면 2023년 전위 의존성 이온 채널이 주요 유형으로 나타났습니다.

검사 방법별로는 자동 전기생리 시스템이 2023년 주요 유형으로 나타났습니다.

용도별로 보면 2023년에는 항부정맥제가 주요 유형이었습니다.

최종사용자별로는 제약회사가 2023년 주요 유형이었습니다.

지역별로는 북미가 2023년 매출에서 선두를 차지했습니다.

HERG 스크리닝 시장 - 세분화 분석 :

세계 HERG 스크리닝 시장은 유형, 이온 채널, 검사 방법, 애플리케이션, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 유형에 따라 유전자 KCNH2와 변이형 KCNH2의 두 가지 범주로 나뉩니다. 유전자 KCNH2는 정상적인 심장 기능 및 약물 상호 작용 평가와 관련이 있으므로 매우 선호됩니다. 변이형 KCNH2는 표적 연구 및 약물 반응 평가를 위해 특정 변이형에 초점을 맞춘 이차적 인 것입니다.

시장은 이온 채널에 따라 전위 의존성 이온 채널, 리간드 의존성 이온 채널, 기계 민감성 이온 채널, 일시적 수용체 전위 등 네 가지 범주로 나뉩니다. 전위 의존성 이온 채널은 심장 기능 및 약물 유발 부정맥에서 중심적인 역할을하기 때문에 매우 선호됩니다. 리간드 의존성 이온 채널은 특정 약물 상호 작용에서 중요합니다. 기계 민감성 채널과 일시적 수용체 전위 채널은 심장 안전성 평가에서 덜 선호됩니다.

HERG 스크리닝 시장 - 지역적 인사이트

북미지역은 탄탄한 제약산업이 존재하고, 심장 안전에 대한 엄격한 규제기준으로 인해 시장을 독점하고 있습니다. 이 지역은 또한 연구개발, 특히 혁신적 신약개발에 많은 투자를 하고 있는 것이 특징입니다. 유럽은 유사한 규제 프레임워크와 정밀의료에 대한 집중적인 노력으로 그 뒤를 잇고 있습니다. 아시아태평양은 의료비 지출 증가, 제약 부문 확대, 의약품 안전에 대한 인식이 높아지면서 빠른 성장 잠재력을 보여주고 있습니다. 중국, 인도 등 신흥 국가은 의료 인프라의 발전과 새로운 치료제에 대한 수요 증가에 힘입어 HERG 스크리닝 기술 채택이 확대되고 있습니다. 이러한 지역별 인사이트는 HERG 스크리닝 시장의 세계 확산과 진화하는 상황을 지원합니다.

HERG 스크리닝 시장 - 경쟁 구도:

Charles River Laboratories International Inc., Cyprotex PLC, Eurofins Scientific, Cerep SA와 같은 주요 기업은 종합적인 HERG 스크리닝 서비스를 제공하는 유명한 기업입니다. 이들 기업은 자동 패치 클램핑, 하이스루풋 스크리닝과 같은 첨단 기술을 활용하여 심장 안전성 평가의 효율성과 정확성을 높이는 데 주력하고 있습니다. 제약 대기업과의 전략적 제휴 및 협력 관계를 통해 시장 범위를 넓히고 맞춤형 솔루션을 제공합니다. 또한 Nanion Technologies와 Sophion Bioscience와 같은 신생 기업은 다양한 의약품 개발 요구에 부응하는 새로운 HERG 스크리닝 플랫폼으로 인기를 끌고 있습니다. 또한 HERG 스크리닝 시장에서 주목할 만한 협업 사례로는 Charles River Laboratories International Inc.와 AstraZeneca의 제휴를 들 수 있습니다. 이 제휴는 HERG 스크리닝 분석을 포함한 새로운 심장 안전성 테스트 패널의 개발 및 검증을 통해 신약 개발 및 약물 개발 노력을 지원하는 것을 목표로 하고 있습니다.

목차

제1장 HERG 스크리닝 시장 개요

  • 조사 범위
  • 시장 추정년

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 HERG 스크리닝의 주요 시장 동향

  • 시장 촉진요인
  • 시장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 HERG 스크리닝 업계 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 구조 분석

제5장 HERG 스크리닝 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 HERG 스크리닝 시장 구도

  • HERG 스크리닝 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업의 분석
    • 신규 기업의 분석

제7장 HERG 스크리닝 시장 : 유형별

  • 개요
    • 유형별 부문 점유율 분석
    • 유전자 KCNH2
    • 변이 KCNH2

제8장 HERG 스크리닝 시장 : 이온채널별

  • 개요
    • 이온채널별 부문 점유율 분석
    • 전위 의존성 이온채널
    • 리간드 의존성 이온채널
    • 기계 감수성
    • 일과성 수용기 전위

제9장 HERG 스크리닝 시장 : 검사법별

  • 개요
    • 검사법별 부문 점유율 분석
    • 수동 패치 클램프 어세이
    • 자동 전기생리학 시스템
    • 인실리코 모델링
    • 결합 어세이

제10장 HERG 스크리닝 시장 : 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 항부정맥약
    • 항정신병약
    • 항생제
    • 항말라리아
    • 항히스타민제

제11장 HERG 스크리닝 시장 : 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 제약회사
    • 계약 연구기관(CRO)
    • 학술연구기관

제12장 HERG 스크리닝 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제13장 주요 벤더 분석 - HERG 스크리닝 업계

  • 경쟁 대시보드
  • 기업 개요
    • Aurora Biomed Inc.
    • Axion Biosystems
    • Cerep SA(a part of Eurofins Scientific)
    • Charles River Laboratories International, Inc.
    • Confluence Discovery Technologies
    • Cyprotex(a division of Evotec SE)
    • Cytocentrics AG
    • Eurofins Discovery
    • Icagen, Inc.(a division of Domain Therapeutics)
    • Metrion Biosciences Ltd.
    • MilliporeSigma(Merck KGaA)
    • Nanion Technologies GmbH
    • Ncardia
    • PerkinElmer, Inc.
    • SB Drug Discovery
    • Sophion Bioscience A/S
    • 기타

제14장 애널리스트의 전방위 전망

KSA 24.06.04

REPORT HIGHLIGHT

HERG Screening Market size was valued at USD 1,124.45 million in 2023, expanding at a CAGR of 10.9% from 2024 to 2032.

The HERG screening market, vital in drug development to assess compounds for cardiac safety, is driven by stringent drug safety regulations necessitating early cardiac risk identification, alongside a rising incidence of cardiac disorders globally. Advancements in drug discovery technologies and precision medicine further bolster demand for sophisticated HERG screening methods. However, challenges such as high equipment costs, data complexity, and ethical concerns around animal models restrict market growth. Opportunities lie in untapped emerging markets, continuous technological advancements enhancing screening efficiency, strategic collaborations between pharmaceutical entities, and screening providers driving innovation in HERG screening tailored for specific therapeutic areas.

HERG Screening Market- Market Dynamics

Rising Drug Innovation and Cardiovascular Disease Prevalence Driving the Market Growth

The HERG screening market is experiencing robust growth driven by increasing drug innovation and the rising prevalence of cardiovascular diseases. For instance, according to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, with an estimated 17.9 million deaths annually. Additionally, the U.S. Food and Drug Administration (FDA) emphasizes the importance of cardiac safety assessments during drug development to mitigate adverse effects, highlighting the critical role of HERG screening. With pharmaceutical companies focusing on developing novel drugs and therapies, the demand for HERG screening services continues to escalate, ensuring safer and more effective treatments for cardiovascular conditions.

HERG Screening Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.9% over the forecast period (2024-2032)

Based on Type segmentation, Gene KCNH2 was predicted to show maximum market share in the year 2023

Based on Ion Channel segmentation, voltage-gated ion channel was the leading type in 2023

Based on Testing Methods segmentation, Automated Electrophysiology Systems was the leading type in 2023

Based on Application segmentation, Antiarrhythmic was the leading type in 2023

Based on end-user segmentation, Pharmaceutical Companies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

HERG Screening Market- Segmentation Analysis:

The Global HERG Screening Market is segmented based on Type, ION Channel, Testing Methods, Application, End User, and Region.

The market is divided into two categories based on Type: Gene KCNH2 and mutant KCNH2. gene KCNH2 is highly preferred due to its relevance in assessing normal cardiac function and drug interactions. Mutant KCNH2 is secondary preferred, focusing on specific variants for targeted studies and drug response evaluations.

The market is divided into four categories based on ION Channel: Voltage-Gated Ion Channel, Ligand-Gated Ion Channel, Mechanosensitive, and Transient receptor potential. Voltage-gated ion channels are highly preferred due to their central role in cardiac function and drug-induced arrhythmia. Ligand-gated ion channels follow, important for specific drug interactions. Mechanosensitive and transient receptor potential channels are less commonly prioritized for cardiac safety assessments.

HERG Screening Market- Geographical Insights

North America dominates the market due to the presence of a well-established pharmaceutical industry and stringent regulatory standards emphasizing cardiac safety. The region is also characterized by substantial investments in research and development, particularly in innovative drug discovery. Europe follows closely, driven by similar regulatory frameworks and a significant focus on precision medicine. Asia Pacific showcases rapid growth potential attributed to increasing healthcare expenditure, expanding pharmaceutical sector, and rising awareness about drug safety. Emerging economies in this region, such as China and India, are witnessing growing adoption of HERG screening technologies fueled by advancements in healthcare infrastructure and a burgeoning demand for novel therapeutics. These geographical insights underscore the global reach and evolving landscape of the HERG screening market.

HERG Screening Market- Competitive Landscape:

Key companies such as Charles River Laboratories International Inc., Cyprotex PLC, Eurofins Scientific, and Cerep SA are prominent players offering comprehensive HERG screening services. These companies focus on leveraging advanced technologies like automated patch clamping and high-throughput screening to enhance efficiency and accuracy in cardiac safety assessments. Strategic partnerships and collaborations with pharmaceutical giants enable them to broaden their market reach and offer tailored solutions. Additionally, emerging players like Nanion Technologies and Sophion Bioscience are gaining traction with novel HERG screening platforms catering to diverse drug development needs. Furthermore, one notable instance of collaboration in the HERG screening market is the partnership between Charles River Laboratories International Inc. and AstraZeneca. This collaboration aimed to develop and validate a new cardiac safety testing panel, including HERG screening assays, to support drug discovery and development efforts.

Recent Developments:

In August 2023, Metrion Biosciences Limited was accepted into the UK GLP Compliance Monitoring Programme by the Medicines and Healthcare Products Regulatory Agency (MHRA). This allows the company to provide GLP-compliant hERG ion channel screening services worldwide.

In March 2020, Charles River Laboratories and Deciphex have partnered to co-develop deep learning-enabled pathology analytics. Charles River will exclusively offer Deciphex's Patholytix preclinical solution.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HERG SCREENING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Aurora Biomed Inc.

Axion Biosystems

Cerep SA (a part of Eurofins Scientific)

Charles River Laboratories International, Inc.

Confluence Discovery Technologies

Cyprotex (a division of Evotec SE)

Cytocentrics AG

Eurofins Discovery

Icagen, Inc. (a division of Domain Therapeutics)

Metrion Biosciences Ltd.

MilliporeSigma (Merck KGaA)

Nanion Technologies GmbH

Ncardia

PerkinElmer, Inc.

SB Drug Discovery

Sophion Bioscience A/S

Others

GLOBAL HERG SCREENING MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Gene KCNH2
  • Mutant KCNH2

GLOBAL HERG SCREENING MARKET, BY ION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Voltage-Gated Ion Channel
  • Ligand-Gated Ion Channel
  • Mechanosensitive
  • Transient Receptor Potential

GLOBAL HERG SCREENING MARKET, BY TESTING METHODS- MARKET ANALYSIS, 2019 - 2032

  • Manual Patch Clamp Assay
  • Automated Electrophysiology Systems
  • In Silico Modeling
  • Binding Assays

GLOBAL HERG SCREENING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Antiarrhythmic
  • Antipsychotic
  • Antibiotic
  • Antimalarial
  • Antihistamine

GLOBAL HERG SCREENING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutions

GLOBAL HERG SCREENING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.HERG Screening Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.HERG Screening Market Snippet by Type
    • 2.1.2.HERG Screening Market Snippet by Ion Channel
    • 2.1.3.HERG Screening Market Snippet by Testing Methods
    • 2.1.4.HERG Screening Market Snippet by Application
    • 2.1.5.HERG Screening Market Snippet by End User
    • 2.1.6.HERG Screening Market Snippet by Country
    • 2.1.7.HERG Screening Market Snippet by Region
  • 2.2.Competitive Insights

3.HERG Screening Key Market Trends

  • 3.1.HERG Screening Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.HERG Screening Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.HERG Screening Market Opportunities
  • 3.4.HERG Screening Market Future Trends

4.HERG Screening Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.HERG Screening Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.HERG Screening Market Landscape

  • 6.1.HERG Screening Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.HERG Screening Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Gene KCNH2
    • 7.1.3.Mutant KCNH2

8.HERG Screening Market - By Ion Channel

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Ion Channel, 2023 & 2032 (%)
    • 8.1.2.Voltage-Gated Ion Channel
    • 8.1.3.Ligand-Gated Ion Channel
    • 8.1.4.Mechanosensitive
    • 8.1.5.Transient receptor potential

9.HERG Screening Market - By Testing Methods

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Testing Methods, 2023 & 2032 (%)
    • 9.1.2.Manual Patch Clamp Assay
    • 9.1.3.Automated Electrophysiology Systems
    • 9.1.4.In Silico Modeling
    • 9.1.5.Binding Assays

10.HERG Screening Market - By Application

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Antiarrhythmic
    • 10.1.3.Antipsychotic
    • 10.1.4.Antibiotic
    • 10.1.5.Antimalarial
    • 10.1.6.Antihistamine

11.HERG Screening Market - By End User

  • 11.1.Overview
    • 11.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2.Pharmaceutical Companies
    • 11.1.3.Contract Research Organizations (CROs)
    • 11.1.4.Academic and Research Institutions

12.HERG Screening Market- By Geography

  • 12.1.Introduction
    • 12.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2.North America
    • 12.2.1.Overview
    • 12.2.2.HERG Screening Key Manufacturers in North America
    • 12.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.5.North America Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
    • 12.2.6.North America Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
    • 12.2.7.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9.U.S.
      • 12.2.9.1.Overview
      • 12.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4.U.S. Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.2.9.5.U.S. Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.2.9.6.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10.Canada
      • 12.2.10.1.Overview
      • 12.2.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4.Canada Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.2.10.5.Canada Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.2.10.6.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.Europe
    • 12.3.1.Overview
    • 12.3.2.HERG Screening Key Manufacturers in Europe
    • 12.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.5.Europe Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
    • 12.3.6.Europe Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
    • 12.3.7.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9.Germany
      • 12.3.9.1.Overview
      • 12.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4.Germany Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.3.9.5.Germany Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.3.9.6.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10.Italy
      • 12.3.10.1.Overview
      • 12.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4.Italy Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.3.10.5.Italy Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.3.10.6.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11.United Kingdom
      • 12.3.11.1.Overview
      • 12.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4.United Kingdom Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.3.11.5.United Kingdom Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.3.11.6.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12.France
      • 12.3.12.1.Overview
      • 12.3.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4.France Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.3.12.5.France Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.3.12.6.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13.Russia
      • 12.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3.Russia Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.3.13.4.Russia Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.3.13.5.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.6.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14.Netherlands
      • 12.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3.Netherlands Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.3.14.4.Netherlands Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.3.14.5.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.6.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15.Sweden
      • 12.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3.Sweden Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.3.15.4.Sweden Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.3.15.5.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.6.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16.Poland
      • 12.3.16.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3.Poland Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.3.16.4.Poland Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.3.16.5.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.6.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17.Rest of Europe
      • 12.3.17.1.Overview
      • 12.3.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4.Rest of the Europe Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.3.17.5.Rest of the Europe Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.3.17.6.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.Asia Pacific (APAC)
    • 12.4.1.Overview
    • 12.4.2.HERG Screening Key Manufacturers in Asia Pacific
    • 12.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.5.Asia Pacific Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
    • 12.4.6.Asia Pacific Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
    • 12.4.7.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9.India
      • 12.4.9.1.Overview
      • 12.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4.India Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.4.9.5.India Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.4.9.6.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10.China
      • 12.4.10.1.Overview
      • 12.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4.China Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.4.10.5.China Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.4.10.6.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11.Japan
      • 12.4.11.1.Overview
      • 12.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4.Japan Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.4.11.5.Japan Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.4.11.6.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12.South Korea
      • 12.4.12.1.Overview
      • 12.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4.South Korea Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.4.12.5.South Korea Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.4.12.6.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13.Australia
      • 12.4.13.1.Overview
      • 12.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4.Australia Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.4.13.5.Australia Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.4.13.6.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14.Thailand
      • 12.4.14.1.Overview
      • 12.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4.Thailand Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.4.14.5.Thailand Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.4.14.6.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15.Indonesia
      • 12.4.15.1.Overview
      • 12.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4.Indonesia Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.4.15.5.Indonesia Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.4.15.6.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16.Philippines
      • 12.4.16.1.Overview
      • 12.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4.Philippines Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.4.16.5.Philippines Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.4.16.6.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17.Rest of APAC
      • 12.4.17.1.Overview
      • 12.4.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4.Rest of APAC Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.4.17.5.Rest of APAC Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.4.17.6.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.Latin America
    • 12.5.1.Overview
    • 12.5.2.HERG Screening Key Manufacturers in Latin America
    • 12.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.5.Latin America Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
    • 12.5.6.Latin America Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
    • 12.5.7.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9.Brazil
      • 12.5.9.1.Overview
      • 12.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4.Brazil Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.5.9.5.Brazil Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.5.9.6.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10.Mexico
      • 12.5.10.1.Overview
      • 12.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4.Mexico Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.5.10.5.Mexico Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.5.10.6.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11.Argentina
      • 12.5.11.1.Overview
      • 12.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4.Argentina Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.5.11.5.Argentina Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.5.11.6.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12.Colombia
      • 12.5.12.1.Overview
      • 12.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4.Colombia Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.5.12.5.Colombia Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.5.12.6.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13.Rest of LATAM
      • 12.5.13.1.Overview
      • 12.5.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4.Rest of LATAM Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.5.13.5.Rest of LATAM Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.5.13.6.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.Middle East and Africa
    • 12.6.1.Overview
    • 12.6.2.HERG Screening Key Manufacturers in Middle East and Africa
    • 12.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.5.Middle East and Africa Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
    • 12.6.6.Middle East and Africa Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
    • 12.6.7.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9.Saudi Arabia
      • 12.6.9.1.Overview
      • 12.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4.Saudi Arabia Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.6.9.5.Saudi Arabia Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.6.9.6.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10.United Arab Emirates
      • 12.6.10.1.Overview
      • 12.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4.United Arab Emirates Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.6.10.5.United Arab Emirates Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.6.10.6.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11.Israel
      • 12.6.11.1.Overview
      • 12.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4.Israel Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.6.11.5.Israel Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.6.11.6.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12.Turkey
      • 12.6.12.1.Overview
      • 12.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4.Turkey Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.6.12.5.Turkey Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.6.12.6.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13.Algeria
      • 12.6.13.1.Overview
      • 12.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4.Algeria Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.6.13.5.Algeria Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.6.13.6.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14.Egypt
      • 12.6.14.1.Overview
      • 12.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4.Egypt Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.6.14.5.Egypt Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.6.14.6.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15.Rest of MEA
      • 12.6.15.1.Overview
      • 12.6.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4.Rest of MEA Market Size and Forecast, By Ion Channel, 2019 - 2032 (US$ Million)
      • 12.6.15.5.Rest of MEA Market Size and Forecast, By Testing Methods, 2019 - 2032 (US$ Million)
      • 12.6.15.6.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13.Key Vendor Analysis- HERG Screening Industry

  • 13.1.Competitive Dashboard
  • 13.2.Company Profiles
    • 13.2.1.Aurora Biomed Inc.
    • 13.2.2.Axion Biosystems
    • 13.2.3.Cerep SA (a part of Eurofins Scientific)
    • 13.2.4.Charles River Laboratories International, Inc.
    • 13.2.5.Confluence Discovery Technologies
    • 13.2.6.Cyprotex (a division of Evotec SE)
    • 13.2.7.Cytocentrics AG
    • 13.2.8.Eurofins Discovery
    • 13.2.9.Icagen, Inc. (a division of Domain Therapeutics)
    • 13.2.10.Metrion Biosciences Ltd.
    • 13.2.11.MilliporeSigma (Merck KGaA)
    • 13.2.12.Nanion Technologies GmbH
    • 13.2.13.Ncardia
    • 13.2.14.PerkinElmer, Inc.
    • 13.2.15.SB Drug Discovery
    • 13.2.16.Sophion Bioscience A/S
    • 13.2.17.Others

14.360 Degree Analyst View

15.Appendix

  • 15.1.Research Methodology
  • 15.2.References
  • 15.3.Abbreviations
  • 15.4.Disclaimer
  • 15.5.Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제